Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Dynamic Light Scattering Technology

April 02, 2022

The DynaPro NanoStar II introduces advanced walk-up capabilities in DLS technology.

Updated Process Control Graphics Terminal

April 02, 2022

Rockwell Automations newest graphic terminals increase user storage, product security, and support for modern peripherals.

Symbiosis Successfully Completes UK Research and Innovation Project to Enhance Supply Chain for ATMPs

April 01, 2022

Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.

Thermo Fisher Introduces New Electroporation System for Large-Scale Cell Therapy Development and Manufacturing

April 01, 2022

Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.

KeyPlants Ships First-of-its-Kind Vaccine Manufacturing Facility to Africa

March 31, 2022

KeyPlants has shipped a first-of-its-kind vaccine manufacturing facility to Senegal in West Africa.

Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care

March 25, 2022

Huma has acquired AstraZeneca’s digital health platform, and AstraZeneca has become a shareholder of Huma in a partnership to accelerate digital-first patient care.

USP Medicine Supply Map Reviews Global API Manufacturing

March 18, 2022

New report released by USP offers a look into API supply-chain vulnerabilities.

Catalent Completes $30 Million Project for Biopharmaceutical Development and Manufacturing in Limoges, France

March 17, 2022

Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.

Novasep Invests €5.1 million in Le Mans Site to Further Expand its Production Capacity for HPAPIs

March 16, 2022

Novasep increases its production capacity for HPAPIs with an investment in its site in Le Mans, France.

Facilitating Biopharma Continuous Manufacturing

March 16, 2022

USP is advancing understanding and developing guidance and standards to assist industry in implementing continuous manufacturing.